Shah MM - Search Results

1

Smoothened antagonists reverse taxane resistance in ovarian cancer.

Steg AD, Katre AA, Bevis KS, Ziebarth A, Dobbin ZC, Shah MM, Alvarez RD, Landen CN. Steg AD, et al. Among authors: shah mm. Mol Cancer Ther. 2012 Jul;11(7):1587-97. doi: 10.1158/1535-7163.MCT-11-1058. Epub 2012 May 2. Mol Cancer Ther. 2012. PMID: 22553355 Free PMC article.

2

Endoglin (CD105) contributes to platinum resistance and is a target for tumor-specific therapy in epithelial ovarian cancer.

Ziebarth AJ, Nowsheen S, Steg AD, Shah MM, Katre AA, Dobbin ZC, Han HD, Lopez-Berestein G, Sood AK, Conner M, Yang ES, Landen CN. Ziebarth AJ, et al. Among authors: shah mm. Clin Cancer Res. 2013 Jan 1;19(1):170-82. doi: 10.1158/1078-0432.CCR-12-1045. Epub 2012 Nov 12. Clin Cancer Res. 2013. PMID: 23147994 Free PMC article.

3

Ovarian cancer stem cells: are they real and why are they important?

Shah MM, Landen CN. Shah MM, et al. Gynecol Oncol. 2014 Feb;132(2):483-9. doi: 10.1016/j.ygyno.2013.12.001. Epub 2013 Dec 7. Gynecol Oncol. 2014. PMID: 24321398 Free PMC article. Review.

4

An ex vivo assay of XRT-induced Rad51 foci formation predicts response to PARP-inhibition in ovarian cancer.

Shah MM, Dobbin ZC, Nowsheen S, Wielgos M, Katre AA, Alvarez RD, Konstantinopoulos PA, Yang ES, Landen CN. Shah MM, et al. Gynecol Oncol. 2014 Aug;134(2):331-7. doi: 10.1016/j.ygyno.2014.05.009. Epub 2014 May 15. Gynecol Oncol. 2014. PMID: 24844596 Free PMC article.

5

Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer.

Dobbin ZC, Katre AA, Steg AD, Erickson BK, Shah MM, Alvarez RD, Conner MG, Schneider D, Chen D, Landen CN. Dobbin ZC, et al. Among authors: shah mm. Oncotarget. 2014 Sep 30;5(18):8750-64. doi: 10.18632/oncotarget.2373. Oncotarget. 2014. PMID: 25209969 Free PMC article.

6

Does a standardized preoperative algorithm of clinical data improve outcomes in patients with ovarian cancer? A quality improvement project.

Shah MM, Leath CA 3rd, Daily LR, McGwin G Jr, Estes JM, Alvarez RD, Straughn JM Jr. Shah MM, et al. Int J Gynecol Cancer. 2015 Jun;25(5):798-801. doi: 10.1097/IGC.0000000000000433. Int J Gynecol Cancer. 2015. PMID: 25950127 Free PMC article.

7

Vulvar histoplasmosis as a rare cause of genital ulceration.

Shine MM, Shah MM, Hanna CA, Bevis KS. Shine MM, et al. Among authors: shah mm. Obstet Gynecol. 2013 Aug;122(2 Pt 2):449-452. doi: 10.1097/AOG.0b013e31829ce0f1. Obstet Gynecol. 2013. PMID: 23884256

8

Fertility preservation in young women with epithelial ovarian cancer.

Wright JD, Shah M, Mathew L, Burke WM, Culhane J, Goldman N, Schiff PB, Herzog TJ. Wright JD, et al. Cancer. 2009 Sep 15;115(18):4118-26. doi: 10.1002/cncr.24461. Cancer. 2009. PMID: 19670446 Free article.

9

The role of Notch and gamma-secretase inhibition in an ovarian cancer model.

Shah MM, Zerlin M, Li BY, Herzog TJ, Kitajewski JK, Wright JD. Shah MM, et al. Anticancer Res. 2013 Mar;33(3):801-8. Anticancer Res. 2013. PMID: 23482747 Free PMC article.

10

Therapeutic role of lymphadenectomy for cervical cancer.

Shah M, Lewin SN, Deutsch I, Burke WM, Sun X, Herzog TJ, Wright JD. Shah M, et al. Cancer. 2011 Jan 15;117(2):310-7. doi: 10.1002/cncr.25408. Epub 2010 Sep 22. Cancer. 2011. PMID: 20862747 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

402 results

Search Page

Filters